Related Experiment Video
Updated: Jul 18, 2026

Diagnosis of Hirschsprung's Disease by Immunostaining Rectal Suction Biopsies for Calretinin, S100 Protein and Protein Gene Product 9.5
Published on: April 26, 2019
Screening for celiac disease in children with recurrent abdominal pain
K P Fitzpatrick1, P M Sherman, M Ipp
1Division of Gastroenterology and Nutrition, The Hospital for Sick Children and University of Toronto, Toronto, Ontario, Canada.
Insights
This study found no increased prevalence of antiendomysial antibodies in children with recurrent abdominal pain compared to healthy children. These findings do not support routine celiac disease screening for children with this symptom in primary care.
Area of Science:
- Pediatric Gastroenterology
- Immunology
- Clinical Diagnostics
Background:
- Celiac disease is a gluten intolerance often presenting with chronic abdominal pain.
- Recurrent abdominal pain is a common complaint in pediatric primary care.
Purpose of the Study:
- To investigate the prevalence of antiendomysial antibodies in children experiencing recurrent abdominal pain.
- To compare this prevalence with that in healthy children.
Main Methods:
- A community-based case-control study involving children with recurrent abdominal pain and healthy controls.
- Measurement of antiendomysial antibodies in serum samples from both groups.
Main Results:
- Out of 173 participants, only 2 (1.2%) tested positive for antiendomysial antibodies.
- The prevalence was 1% in children with recurrent abdominal pain and 1% in controls, with no statistically significant difference.
Conclusions:
- No association was found between recurrent abdominal pain and antiendomysial antibody prevalence in this study.
- Screening for celiac disease in children with recurrent abdominal pain in primary care is not supported by these data.
Background:
The clinical presentation of celiac disease--a life-long gluten intolerance--may be characterized by chronic abdominal pain. The objective of this study was to determine if children with recurrent abdominal pain had a higher prevalence of antiendomysial antibodies (a serologic marker of celiac disease) compared with healthy children.
Methods:
Children with recurrent abdominal pain and healthy control participants were recruited from the offices of community pediatricians. Serum samples were drawn and antiendomysial antibodies were measured in both groups. Demographic data included age, gender, height, and weight.
Results:
A total of 200 children were recruited, of whom 173 (87%) had serum samples drawn. Of these, 92 were children with recurrent abdominal pain and 81 were control participants. Only 2 of the 173 samples (1.2%) were positive for antiendomysial antibody. The frequency of antiendomysial antibody positivity in children with recurrent abdominal pain was 1 in 92 (1%; 95% confidence interval, 0-6%) compared with 1 in 81 (1%; 95% confidence interval, 0-7%) in control participants.
Conclusions:
This community-based case-control study found no association between recurrent abdominal pain and the prevalence of antiendomysial antibody. Therefore, these data do not support screening for celiac disease in the child with classic recurrent abdominal pain in the primary care setting.
More Related Videos
06:46A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
05:56Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
Published on: August 29, 2025
Related Concept Videos
Other Disorders of Digestive System
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Chronic Pancreatitis II: Collaborative Care
Assessment:
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Serum Laboratory Studies, Stool Test, Breath Test